Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0464
Full Text
Open PDFAbstract
Available in full text
Date
November 7, 2018
Authors
Publisher
American Association for Cancer Research (AACR)